Degradation

Degradation is the chemical breakdown of a compound into one or more different substances over time. The original molecule — whether a pharmaceutical, a plant extract, or a synthesised compound — loses structural integrity when exposed to environmental stressors: ultraviolet light cleaves chemical bonds, heat accelerates reactive processes, moisture triggers hydrolysis, and atmospheric oxygen drives oxidation.

The result is a sample containing less of the intended active compound and potentially containing breakdown products whose identities and effects are unknown. This is why storage conditions — temperature, humidity, light exposure, and container material — matter not just for potency but for safety.

How it works · its role

Different degradation pathways attack different chemical bonds. Hydrolysis uses water to break ester, amide, or ether bonds — functional groups common across alkaloids and many synthetic compounds. Oxidation targets electron-rich sites such as aromatic rings, carbon–carbon double bonds, and nitrogen atoms, often producing hydroxylated or dealkylated products.

Photolysis occurs when photons carry enough energy to rupture bonds directly, or generate reactive intermediates that attack the molecule further. Thermolysis is analogous but heat-driven. These pathways often interact: a compound stored warm, humid, and under light may degrade faster than any single route predicts, because products of one reaction can seed another.

Relevance to substances & effects

Psychoactive compounds vary considerably in stability. LSD degrades readily under heat, UV light, and oxidation, producing byproducts such as iso-LSD that are largely inactive; psilocybin in dried mushrooms holds up well in cool, dark, dry conditions but breaks down noticeably with moisture or elevated temperature. Delta-9-THC slowly oxidises over storage to cannabinol (CBN), shifting the pharmacological profile toward a more sedating character.

The harm reduction implications are twofold. A degraded sample delivers less of the intended compound, making dose estimation unreliable. Breakdown products are often uncharacterised — some inert, others potentially active or carrying their own risks. Reagent tests calibrated to the parent compound can give misleading readings on a heavily degraded sample, which is one reason proper storage conditions affect test reliability as much as potency.